XPO1 Enables Adaptive Regulation of mRNA Export Required for Genotoxic Stress Tolerance in Cancer Cells
Rossella Marullo(Regeneron (United States)), Leandro Cerchietti(Cornell University), Nicolás Di Siervi(Cornell University), John N. Allan(Cornell University), John P. Leonard(New York University), Peter Martin(Northwestern University), Koen van Besien(University Hospitals of Cleveland), Adrienne A. Phillips(Palmetto Hematology Oncology), Jia Ruan(Cornell University), María V. Revuelta(Cornell University), Tsiporah B. Shore(Cornell University), Katherine L. B. Borden(Northwestern University), Biljana Culjkovic‐Kraljacic(Institute for Research in Immunology and Cancer), Juan Lara-Garcia(Cornell University), Nahuel Zamponi(Cornell University), Jingmei Hsu(Cancer Research Institute), Sarah C. Rutherford(NewYork–Presbyterian Hospital), Nikita Kotlov(Addgene), Zhengming Chen(Cornell University), Giorgio Inghirami(Cornell University), Sebastian Mayer(Mount Sinai Hospital), Richard R. Furman(Cornell University)
Cited by 26
Related Papers
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
|New England Journal of Medicine|2018|2.3k
Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2013|2.2k
Targeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell Lymphoma
|New England Journal of Medicine|2013|1.7k
Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2014|1.7k
Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia
|New England Journal of Medicine|2014|1.6k